Concord Biotech’s IPO to open on 4th August, 2023

The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.

Market success of Novo Nordisk’s obesity drug likely to be delayed in Japan, says GlobalData

In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1

Upsurge in pink eye conjunctivitis cases in the country

Take proper precautions and seek timely treatment!

Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer

Marks the World Head & Neck Cancer Day at the OCTF Conference

Update on medical colleges in aspirational districts: PIB

AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur

M&A activity of pharma CMOs will continue despite challenging borrowing environment, says GlobalData

CMOs showed an increasing reluctance to take on debt in 2022

Wockhardt Hospitals, Mira Road launches training program for family physician

To equip them with the latest knowledge and skills to handle patients coming to them in a better way

Helping Hand Foundation launches screening for glaucoma in Hyderabad

First of its kind screening for Glaucoma at grass root level over 10k screened already

Dupixent is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis

Bausch + Lomb acquires Blink eye drops

The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care